Hypertension —Opportunities and Challenges

Abstract

Hypertension-Opportunities and ChallengesJohn E. Hall, Editor-in-Chief W e greatly appreciate the privilege and challenge of serving as stewards of Hypertension for the next 5 years.Serving the journal is a privilege because Hypertension, since its inception, has been the premier journal in its field.At the same time, we face the challenge of increasing competition from other cardiovascular and hypertension journals, and we must rapidly adapt to the growing movement toward electronic publishing.The fact that Hypertension serves a broad readership with diverse research and clinical interests is a challenge and an opportunity.Although it is unlikely that we will please everyone, we keep such a goal in mind.Our intention is to publish in Hypertension original research papers, reviews, and special articles of such high caliber that they will receive the highest approval of those most competent to judge them.Hypertension was born in 1979 under the pioneering editorship of Harriet Dustan and her associate editors, Suzanne Oparil and Henry Overbeck, who clearly articulated the guiding principles of the journal: 1 "Its editors are committed to developing a journal of high quality that is broadly based and covers all aspects of the field, not just a part of it-a journal that explores new areas, not just those that are already accepted as important.The field of hypertension is multidisciplinary, and the journal will serve a purpose only if it provides bridges among the many disciplines.It must stimulate thought and air scientific controversies.It must be a forum not only for results of laboratory investigation but also clinical research.It must inform its readers of events happening outside the laboratory and the medical center that may impinge on the ability to do research or on the care of hypertensive patients.It must serve the science of hypertension and promote the better care of hypertensive patients."Subsequent editorial teams have, fortunately, embraced these principles, and Hypertension has thrived despite the proliferation of other journals with similar research interests.Hypertension, led by 4 outstanding teams of editors, has risen to many challenges over the 23 years of its existence and remains the premier journal in the field.In 1984, Edgar Haber and his associate editors, Victor Dzau, Robert Graham, and Randall Zusman, broadened the scope of the journal by rapidly incorporating the emerging discipline of molecular biology. 2 Allyn Mark assumed the editorship in 1989 and, along with associate editors Gerald DiBona (who later served as editor-in-chief), Francois Abboud, Donald Heisted, and Larry Tobacman, brought a high level of efficiency to the review process.This team also emphasized an "attentive and collegial editorship" and the importance of service to the authors and readers.3 The most recent team of editors, Edward Frohlich, Gabriel Navar, and Richard Ré, 4 further reduced the time for review of manuscripts and guided the journal to a record level of 1278 submissions for the year 2000, with even higher numbers expected for 2001.We are grateful to the previous editorial teams for Hypertension's current strong foundation, and we plan to take full advantage of their talents and experience by inviting members from each team to serve as consulting editors.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 18 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.